Gan Li Pharmaceuticals competes on recombinant insulin markets

The company, which has just started clinical phase III in the USA on glargine, in 2015 ranked 3d in the Chinese insulin market, with 11.2%, behind 53.1% of Nordisk and 26.7% of Sanofi, but has overtaken Eli Lilly (9%). Prices offered by Gan Li are about 20 % under...

New type of rapeseed oil approved in China

CAAS has approved a novel type of rapeseed oil „Zhong Yusha 1“, obtained from radiation-induced mutagenesis of an African variety of rapeseed. Characteristics are high yield, high oil content and good quality. The tuber seed oil content is 31.3%, which is the oilseed...

East Asia VLBI radio telescope Network starts scientific commission

The network is composed of 21 radio telescopes from China, Japan and South Korea. Some new telescopes are under construction (e.g., a 110 meter telescope in Xinjiang, China) or planned (Thailand VLBI network, the expansion of KVN), continuously enlarging the EAVN...